Post by barb43 on May 12, 2020 2:47:19 GMT
The Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing.
With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than one million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked #1 in the nation by U.S. News and World Report.
Such a highly recognized organization is the one to listen to when they speak on the possibility of developing a vaccine for Covid-19. The following presents a lot of good information on the potential vaccine development and the time it might take to do it right.
COVID-19 (coronavirus) vaccine: Get the facts - The Mayo Clinic
www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vaccine/art-20484859
Valuable information continues from this point on throughout the article.
With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than one million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked #1 in the nation by U.S. News and World Report.
Such a highly recognized organization is the one to listen to when they speak on the possibility of developing a vaccine for Covid-19. The following presents a lot of good information on the potential vaccine development and the time it might take to do it right.
COVID-19 (coronavirus) vaccine: Get the facts - The Mayo Clinic
www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vaccine/art-20484859
Coronavirus vaccine research
Coronaviruses are a family of viruses that cause illnesses such as the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). COVID-19 is caused by a virus that's closely related to the one that causes SARS. For this reason, scientists named the new virus SARS-CoV-2.
While vaccine development can take years, researchers aren't starting from scratch to develop a COVID-19 vaccine. Past research on SARS and MERS vaccines has identified potential approaches.
Coronavirus vaccine challenges
Past research on vaccines for coronaviruses has also identified some challenges to developing a COVID-19 vaccine, including:
Ensuring vaccine safety. Several vaccines for SARS have been tested in animals. Most of the vaccines improved the animals' survival but didn't prevent infection. Some vaccines also caused complications, such as lung damage. A COVID-19 vaccine will need to be thoroughly tested to make sure it's safe for humans.
Providing long-term protection. After infection with coronaviruses, re-infection with the same virus — though usually mild and only happening in a fraction of people — is possible after a period of months or years. An effective COVID-19 vaccine will need to provide people with long-term infection protection.
Protecting older people. People older than age 50 are at higher risk of severe COVID-19. But older people usually don't respond to vaccines as well as younger people. An ideal COVID-19 vaccine would work well for this age group.
Coronaviruses are a family of viruses that cause illnesses such as the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). COVID-19 is caused by a virus that's closely related to the one that causes SARS. For this reason, scientists named the new virus SARS-CoV-2.
While vaccine development can take years, researchers aren't starting from scratch to develop a COVID-19 vaccine. Past research on SARS and MERS vaccines has identified potential approaches.
Coronavirus vaccine challenges
Past research on vaccines for coronaviruses has also identified some challenges to developing a COVID-19 vaccine, including:
Ensuring vaccine safety. Several vaccines for SARS have been tested in animals. Most of the vaccines improved the animals' survival but didn't prevent infection. Some vaccines also caused complications, such as lung damage. A COVID-19 vaccine will need to be thoroughly tested to make sure it's safe for humans.
Providing long-term protection. After infection with coronaviruses, re-infection with the same virus — though usually mild and only happening in a fraction of people — is possible after a period of months or years. An effective COVID-19 vaccine will need to provide people with long-term infection protection.
Protecting older people. People older than age 50 are at higher risk of severe COVID-19. But older people usually don't respond to vaccines as well as younger people. An ideal COVID-19 vaccine would work well for this age group.
Valuable information continues from this point on throughout the article.